MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1457.16%
Quick Ratio
1457.16%
Cash Ratio
271.78%
Debt to Asset Ratio
23.00%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Less accumulated depreciation
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Long-term lease liability
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
219,825
288,291
294,944
267,960
Marketable securities
933,102
923,361
950,266
807,010
Prepaid expenses and other current assets
25,668
55,301
23,478
23,577
Total current assets
1,178,595
1,266,953
1,268,688
1,098,547
Total property and equipment
202,415
200,979
198,627
196,891
Less accumulated depreciation
104,809
99,732
94,127
88,601
Property and equipment, net
97,606
101,247
104,500
108,290
Restricted cash
6,711
6,693
6,676
6,656
Operating lease right-of-use assets
95,586
98,148
100,679
96,995
Other assets
7,857
7,757
634
593
Total assets
1,386,355
1,480,798
1,481,177
1,311,081
Accounts payable
13,099
12,286
10,231
9,545
Accrued expenses and other current liabilities
40,406
39,291
55,267
42,314
Current portion of derivative liabilities
9,400
5,200
7,700
6,500
Current portion of deferred revenue
0
304
6,659
110,320
Current portion of lease liability
15,207
14,781
14,364
12,688
Current portion of contingent consideration liabilities
2,771
2,703
2,714
1,192
Total current liabilities
80,883
74,565
96,935
182,559
Long-term lease liability
131,893
135,848
139,759
138,732
Long-term portion of contingent consideration liabilities
5,586
5,449
5,952
6,708
Long-term portion of deferred revenue
-
-
0
10,160
Long-term portion of derivative liabilities
-
-
0
6,654
Long-term portion of debt
100,258
100,193
-
-
Other liabilities
293
305
173
266
Total liabilities
318,913
316,360
242,819
345,079
Common stock, 0.01 par value 250,000,000 shares authorized, 103,264,636 and 101,748,962 issued and outstanding at june 30, 2026 and december 31, 2025, respectively
1,033
1,027
1,017
1,014
Additional paid-in capital
2,926,813
2,900,018
2,877,449
2,855,118
Accumulated other comprehensive (loss) income
-2,189
-1,070
1,111
790
Accumulated deficit
-1,858,215
-1,735,537
-1,641,219
-1,890,920
Total stockholders' equity
1,067,442
1,164,438
1,238,358
966,002
Total liabilities and stockholders' equity
1,386,355
1,480,798
1,481,177
1,311,081
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$933,102K (7.47%↑ Y/Y)Cash and cashequivalents$219,825K (-22.08%↓ Y/Y)Prepaid expenses andother current assets$25,668K (2.15%↑ Y/Y)Total property andequipment$202,415K (5.43%↑ Y/Y)Total current assets$1,178,595K (0.27%↑ Y/Y)Property and equipment,net$97,606K (-10.31%↓ Y/Y)Operating leaseright-of-use assets$95,586K (-4.00%↓ Y/Y)Other assets$7,857K (1076.20%↑ Y/Y)Restricted cash$6,711K (1.18%↑ Y/Y)Less accumulateddepreciation$104,809K (26.01%↑ Y/Y)Total assets$1,386,355K (-0.35%↓ Y/Y)Total liabilities andstockholders' equity$1,386,355K (-0.35%↓ Y/Y)Total stockholders'equity$1,067,442K (1.97%↑ Y/Y)Total liabilities$318,913K (-7.39%↓ Y/Y)Accumulated deficit-$1,858,215K (-4.50%↓ Y/Y)Accumulated othercomprehensive (loss) income-$2,189K (-21990.00%↓ Y/Y)Additional paid-in capital$2,926,813K (3.64%↑ Y/Y)Long-term lease liability$131,893K (-7.02%↓ Y/Y)Long-term portion of debt$100,258K Total currentliabilities$80,883K (-53.55%↓ Y/Y)Long-term portion ofcontingent consideration...$5,586K (370.99%↑ Y/Y)Other liabilities$293K (-17.93%↓ Y/Y)Common stock, 0.01 parvalue 250,000,000...$1,033K (2.48%↑ Y/Y)Accrued expenses andother current...$40,406K (-1.22%↓ Y/Y)Current portion of leaseliability$15,207K (17.44%↑ Y/Y)Accounts payable$13,099K (24.09%↑ Y/Y)Current portion ofderivative liabilities$9,400K (141.03%↑ Y/Y)Current portion ofcontingent consideration...$2,771K

Beam Therapeutics Inc. (BEAM)

Beam Therapeutics Inc. (BEAM)